866-997-4948(US-Canada Toll Free)

Sequenta, Inc. - Product Pipeline Analysis

Published By :

GlobalData

Published Date : Dec 2012

Category :

Surgical Equipment

No. of Pages : 25 Pages


Sequenta, Inc. (Sequenta) is a venture funded biotechnology company. It discovers and develops clinical diagnostics based on the understanding of immune system status. Sequenta improve patient care in immune cells mediated diseases through measurements of lymphocyte diversity. The company commercializes LymphoSIGHT platform to use in clinical and diverse set of diseases. This technology combines multiplexed PCR assays and algorithms to analyze next generation sequencing data. Sequenta uses sequencing based minimal residual disease detection as a clinical decision making tool through ClonoSIGHT test. It predicts and monitors patients with lymphoid malignancies. The company is headquartered in San Francisco, California, the US.

This report is a source for data, analysis and actionable intelligence on the Sequenta, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 3
List of Figures 3

Key Facts 4
Sequenta, Inc. - Major Products and Services 5
Sequenta, Inc. Pipeline Products by Equipment Type 6
Sequenta, Inc. Pipeline Products by Development Stage 8
Sequenta, Inc. Pipeline Products by Therapy Area 10
Sequenta, Inc. Pipeline Products by Milestone Summary 12
ClonoSIGHT 14
ClonoSIGHT Product Status 14
ClonoSIGHT Product Description 14
ClonoSIGHT Product Milestone 14
Diagnostic Test - Auto-Immune Disease 16
Diagnostic Test - Auto-Immune Disease Product Status 16
Diagnostic Test - Auto-Immune Disease Product Description 16
Diagnostic Test - Infection 17
Diagnostic Test - Infection Product Status 17
Diagnostic Test - Infection Product Description 17
Sequenta, Inc. - Key Competitors 18
Sequenta, Inc. - Key Employees 19
Sequenta, Inc. - Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Sequenta, Inc., Recent Developments 21
Oct 24, 2012: Sequenta Receives CLIA Certification For Clinical Test Based On LymphoSIGHT Platform 21
Aug 13, 2012: Sequentas LymphoSIGHT Platform Included In Phase II Mantle Cell Lymphoma Clinical Trial 21
Aug 06, 2012: SWOG Selects Sequentas LymphoSIGHT Platform For Use In 180-Patient Mantle Cell Lymphoma Clinical Trial 22
Aug 06, 2012: SWOG Selects Sequentas LymphoSIGHT Platform For Use In Mantle Cell Lymphoma Clinical Trial 22
Jun 15, 2012: Data From Sequentas LymphoSIGHT Platform For Detection Of Minimal Residual Disease Presented At European Hematology Association Meeting 23
Dec 13, 2011: Sequenta And Collaborators Presented Key Data Using Novel Sequencing Technology To Predict Clinical Relapse 23

Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Table


Sequenta, Inc., Key Facts 1
Sequenta, Inc. Key Pipeline Products by Equipment Type 1
Sequenta, Inc. Key Pipeline Products by Therapy Area 1
Sequenta, Inc. Key Pipeline Products by Development Stage 1
Sequenta, Inc., Key Facts 4
Sequenta, Inc., Major Products and Services 5
Sequenta, Inc. Number of Pipeline Products by Equipment Type 6
Sequenta, Inc. Pipeline Products by Equipment Type 7
Sequenta, Inc. Number of Pipeline Products by Development Stage 8
Sequenta, Inc. Pipeline Products by Development Stage 9
Sequenta, Inc. Number of Pipeline Products by Therapy Area 10
Sequenta, Inc. Pipeline Products by Therapy Area 11
Sequenta, Inc. Number of Pipeline Products By Milestone Summary 12
Sequenta, Inc. Pipeline Products by Milestone Summary 13
ClonoSIGHT - Product Status 14
ClonoSIGHT - Product Description 14
ClonoSIGHT - Product Milestone 14
Diagnostic Test - Auto-Immune Disease - Product Status 16
Diagnostic Test - Auto-Immune Disease - Product Description 16
Diagnostic Test - Infection - Product Status 17
Diagnostic Test - Infection - Product Description 17
Sequenta, Inc., Key Employees 19

List of Chart


Sequenta, Inc. Key Pipeline Products by Equipment Type 1
Sequenta, Inc. Pipeline Products by Equipment Type 6
Sequenta, Inc. Pipeline Products by Development Stage 8
Sequenta, Inc. Pipeline Products by Therapy Area 10
Sequenta, Inc. Pipeline Products by Milestone Summary 12

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *